XNK Therapeutics AB (“XNK”) today announced its European patent for the process of expanding NK cells has been validated in 18 countries across the region. The patent covers XNK’s production…
XNK Therapeutics AB (“XNK”) today announced that Japan has granted the company a patent for its process of expanding NK cells The patent covers XNK’s production methods for expansion and…
XNK Therapeutics AB (“XNK”) today announced it has received a European patent for the process of expanding NK cells. The patent covers XNK’s production methods for large scale expansion and…
